BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera, and reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction for the next 5 years.
The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. The types of cell culture and the products from cell culture technology are also portrayed. Also covered are the advantages and disadvantages of the use of various types of media.
A detailed analysis of the structure of the cell culture industry has been conducted. This includes the biotechnology reagents, media, and the sera used. Revenues are broken down by region. Sales figures are estimated for the 5-year period from 2010 through 2015.
Applications for the cell culture industry—media, sera, and reagents used in biotechnology—are also discussed separately, with an emphasis on the usage in the research, production, and contract segments. This report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
Demand for cell culture products, namely, media, sera, and reagents, is increasing with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life-sciences industry has witnessed major developments in the past three decades. Research and development (R&D) spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are pointing this market in a new direction. During the evolution of cell culture technologies, a number of disciplines, such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering, have been successfully incorporated into the cell culture field.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of types of media used in light of the new technologies, growing competition, and changing customer needs.
This study contributes to the areas of market growth in the cell culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the biotechnology, pharmaceutical, and medical markets. BCC analyzes each market and its applications by its need for development of new medications through cell culture techniques, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
Both primary and secondary research methodologies were used in preparing this market research report. BCC conducted a comprehensive search of the literature, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Many companies within the industry were contacted to obtain data for this study. Included were manufacturers and end users of biopharmaceutical and pharmaceutical companies through their production, research, and contract manufacturing/research lines. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen to 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; andThe Dynamic Media, Sera and Reagent Market in Biotechnology.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.